04.19.24 -- How To Complete Projects On Time

In 2021 on Episode 13, Vor Bio’s President and CEO, Dr. Robert Ang shared data about the company’s lead eHSC product candidate. Dr. Ang is back to talk to Cell & Gene: The Podcast about how Vor has treated 8 patients demonstrating clinical proof of concept and is also in the clinic with a CAR-T that could be used in combination with shielded stem cell transplants. Listen now!

The rising demand for vaccines and complex biotherapeutics has led to an increased role for CDMOs in the development process when it comes to characterizing impurities to ensure product quality.

While a few red flags are common during any submission, several occurring in concert can precipitate a submission crisis. Learn how these can be avoided in this article.

Get several pointers on how to facilitate a transition to an agile, multi-faceted, and continuous risk and issue management approach aligned with the Statistical Analysis Plan.

Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based upon which countries are involved and the types of services required.

Feeling left behind by the sudden digitization of clinical trials? Decentralized clinical trials can be adapted to best serve the patient population, condition, or therapy you’re investigating.

The transition of ongoing clinical trials to meet CTR requirements can be challenging. Examine some key considerations, including substantial modification processes and strategic dossier updates.